Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för bufotenin. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

12 träffar

Bibliografisk träff 2011-05-23

Stimulus control by 5-methoxy-N,N-dimethyltryptamine in wild-type and CYP2D6-humanized mice.

Winter JC, Amorosi DJ, Rice KC, Cheng K, Yu AM.

Pharmacol Biochem Behav · comparative study; research-article; journal article; research support, n.i.h., extramural · DOI 10.1016/j.pbb.2011.05.015

Bibliografisk träff 2010-10-01

Psychedelic 5-methoxy-N,N-dimethyltryptamine: metabolism, pharmacokinetics, drug interactions, and pharmacological actions.

Shen HW, Jiang XL, Winter JC, Yu AM.

Curr Drug Metab · research-article; review; journal article; research support, n.i.h., extramural · DOI 10.2174/138920010794233495

Bibliografisk träff 2010-03-03

Effects of monoamine oxidase inhibitor and cytochrome P450 2D6 status on 5-methoxy-N,N-dimethyltryptamine metabolism and pharmacokinetics.

Shen HW, Wu C, Jiang XL, Yu AM.

Biochem Pharmacol · research-article; journal article; research support, n.i.h., extramural · DOI 10.1016/j.bcp.2010.02.020

Bibliografisk träff 2010-01-01

Elevated urine levels of bufotenine in patients with autistic spectrum disorders and schizophrenia.

Emanuele E, Colombo R, Martinelli V, Brondino N, Marini M, Boso M, Barale F, Politi P.

Neuro Endocrinol Lett · research support, non-u.s. gov't; journal article

Bibliografisk träff 2009-03-19

Sudden death associated with intravenous injection of toad extract.

Kostakis C, Byard RW.

Forensic Sci Int · journal article; case reports · DOI 10.1016/j.forsciint.2009.02.006

Bibliografisk träff 2005-01-01

Potentially hallucinogenic 5-hydroxytryptamine receptor ligands bufotenine and dimethyltryptamine in blood and tissues.

Kärkkäinen J, Forsström T, Tornaeus J, Wähälä K, Kiuru P, Honkanen A, Stenman UH, Turpeinen U, Hesso A.

Scand J Clin Lab Invest · research support, non-u.s. gov't; journal article · DOI 10.1080/00365510510013604

Bibliografisk träff 2001-07-01

Pharmañopo-psychonautics: human intranasal, sublingual, intrarectal, pulmonary and oral pharmacology of bufotenine.

Ott J.

J Psychoactive Drugs · review; journal article · DOI 10.1080/02791072.2001.10400574

Bibliografisk träff 1996-07-01

Bufo toads and bufotenine: fact and fiction surrounding an alleged psychedelic.

Lyttle T, Goldstein D, Gartz J.

J Psychoactive Drugs · historical article; review; journal article · DOI 10.1080/02791072.1996.10472488

Bibliografisk träff 1995-11-01

Bufotenine reconsidered as a diagnostic indicator of psychiatric disorders.

Takeda N, Ikeda R, Ohba K, Kondo M.

Neuroreport · clinical trial; journal article · DOI 10.1097/00001756-199511270-00024

Bibliografisk träff 1995-07-01

Tissue distribution, metabolism and effects of bufotenine administered to rats.

Fuller RW, Snoddy HD, Perry KW.

Neuropharmacology · journal article · DOI 10.1016/0028-3908(95)00049-c

Bibliografisk träff 1985-11-01

Bufotenine reconsidered.

McLeod WR, Sitaram BR.

Acta Psychiatr Scand · journal article · DOI 10.1111/j.1600-0447.1985.tb02638.x

Bibliografisk träff 1978-05-01

Dual mechanism of the stimulant action of N,N-dimethyl-5-hydroxy-tryptamine (bufotenine) on cardiac sympathetic nerves.

Fozard JR, Mobarok Ali AT.

Eur J Pharmacol · journal article · DOI 10.1016/0014-2999(78)90218-2